menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Fucosyltra...
source image

Bioengineer

2w

read

212

img
dot

Image Credit: Bioengineer

Fucosyltransferase 11 Inhibits Ferroptosis in Gastric Cancer

  • The study explores the role of Fucosyltransferase 11 (FUT11) in regulating ferroptosis in gastric cancer by modulating the antioxidative enzyme GPX4.
  • Ferroptosis, an iron-dependent cell death pathway, plays a crucial role in cancer cell proliferation and survival, with FUT11 identified as a key player in gastric cancer progression.
  • FUT11 overexpression in gastric cancer cells correlates with advanced disease stage and poor patient outcomes, making it a potential biomarker for aggressive gastric cancer.
  • Knockdown of FUT11 led to decreased cell proliferation in gastric cancer cell lines, highlighting its role in sustaining tumor growth.
  • FUT11 inhibition resulted in reduced GPX4 levels, a defender against ferroptosis, leading to increased lipid peroxidation and ferroptotic cell death in gastric cancer cells.
  • Overexpressing GPX4 in FUT11-deficient cells rescued cells from ferroptosis, demonstrating the link between FUT11, GPX4 expression, and ferroptotic pathways.
  • In mouse xenograft models, FUT11 knockdown impaired tumor growth, whereas GPX4 overexpression counteracted this effect, underscoring the therapeutic potential of targeting this pathway.
  • The study highlights FUT11 as a promising target to sensitize gastric cancer cells to ferroptosis, offering new avenues for cancer treatment beyond conventional therapies.
  • Inhibiting FUT11 or modulating its downstream effectors could potentially overcome therapeutic resistance in advanced gastric tumors through ferroptotic cell death induction.
  • The research underscores the intricate interplay between glycosylation enzymes like FUT11, ferroptosis regulation, and cancer cell survival, paving the way for innovative therapeutic strategies.

Read Full Article

like

12 Likes

For uninterrupted reading, download the app